Clinical trial
An Early Feasibility Study to Explore a Novel Objective Pain Measurement Using a Wearable Biosensor and a Novel Mobile Platform in Patients With Endometriosis (OPINE)
NCT04318275 is registered in ClinicalTrials.gov with Biofourmis Singapore Pte Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Early Feasibility Study to Explore a Novel Objective Pain Measurement Using a Wearable Biosensor and a Novel Mobile Platform in Patients With Endometriosis (OPINE)
- Lead sponsor
- Biofourmis Singapore Pte Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 6, 2020
- Completion date
- February 22, 2022
- Enrollment
- 90 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.